Safety and trough concentrations of nevirapine prophylaxis given daily, twice weekly, or weekly in breast-feeding infants from birth to 6 months. [electronic resource]
Producer: 20040106Description: 482-90 p. digitalISSN:- 1525-4135
- Acquired Immunodeficiency Syndrome -- prevention & control
- Adolescent
- Adult
- Anti-HIV Agents -- administration & dosage
- Breast Feeding
- Epidemiologic Research Design
- Female
- Humans
- Infant
- Infant, Newborn
- Maternal Age
- Metabolic Clearance Rate
- Nevirapine -- administration & dosage
- Pregnancy
- Pregnancy Complications, Infectious -- prevention & control
- Safety
- South Africa
- Time Factors
- Zimbabwe
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.